HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Repression of PKR mediates palmitate-induced apoptosis in HepG2 cells through regulation of Bcl-2.

Abstract
The present study shows that double-stranded RNA-dependent protein kinase (PKR) regulates the protein expression level and phosphorylation of Bcl-2 and plays an anti-apoptotic role in human hepatocellular carcinoma cells (HepG2). In various types of cells, saturated free fatty acids (FFAs), such as palmitate, have been shown to induce cellular apoptosis by several mechanisms. Palmitate down-regulates the activity of PKR and thereby decreases the level of Bcl-2 protein, mediated in part by reduced activation of the NF-kappaB transcription factor. In addition to the level of Bcl-2 protein, the phosphorylation of Bcl-2 at different amino acid residues, such as Ser70 and Ser87, is also important in regulating cellular apoptosis. The decrease in the phosphorylation of Bcl-2 at Ser70 upon exposure to palmitate is mediated by inhibition of PKR and possibly by c-Jun N-terminal kinase (JNK), whereas the phosphorylation of Bcl-2 at Ser87 is unaffected by palmitate or PKR. In summary, PKR mediates the regulation of the protein level and the phosphorylation status of Bcl-2, providing a novel mechanism of palmitate-induced apoptosis in HepG2 cells.
AuthorsXuerui Yang, Christina Chan
JournalCell research (Cell Res) Vol. 19 Issue 4 Pg. 469-86 (Apr 2009) ISSN: 1748-7838 [Electronic] England
PMID19259124 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • NF-kappa B
  • Palmitates
  • Proto-Oncogene Proteins c-bcl-2
  • eIF-2 Kinase
  • JNK Mitogen-Activated Protein Kinases
Topics
  • Apoptosis
  • Cell Line, Tumor
  • Down-Regulation
  • Humans
  • JNK Mitogen-Activated Protein Kinases (metabolism)
  • NF-kappa B (metabolism)
  • Palmitates (pharmacology)
  • Phosphorylation
  • Proto-Oncogene Proteins c-bcl-2 (metabolism)
  • eIF-2 Kinase (antagonists & inhibitors, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: